*Given my track record with stock picks, you might want to take my predictions with a grain of salt—low sodium, of course.

The dawn of the weight loss medication era, led by heavyweights like Ozempic, has even industry stalwarts like Nestle wondering, "To slim or not to slim?"

Nestle, the esteemed creator of our beloved break-time KitKat, is now conjuring up delights for the calorie-counting crowd. Not to be outdone, General Mills has leapt ahead with its Annie’s Macaroni & Cheese “Super Mac,” answering the question nobody asked: "What if our mac 'n' cheese had more protein?"

General Mills is also apparently whipping up new concoctions by creating lesser evil versions of Betty Crocker's sugary delights. Because nothing says "I'm managing my weight" quite like a lower sodium, lower sugar brownie.

As the GLP-1 brigade—starring Ozempic, Mounjaro, and Wegovy—rides high, our traditional munchies are feeling the pinch, underscored by a whopping 300 million Google searches for GLP-1 obesity drugs.

On Reddit's digital vines, users report Ozempic transforming the taste of coffee and chocolate, turning them into estranged relatives of their delightful selves. This twist could spell trouble for Nestle, a behemoth fuelled by the sweet allure of Nespresso and other treats, which brewed a hefty $7.2 billion in 2023 alone.

Yet, in the scramble for first player advantage and the health-conscious consumer's heart, I'm placing my bets on those brands whipping up a packaging makeover—boosting protein's profile while letting sugars and carbs vanish behind the curtain.

But wait, could this be my own Baader-Meinhof/frequency illusion moment? Like noticing Teslas (or in this case, protein-packed labels) everywhere after someone talks about them to you? Perhaps.

If you want to gain an edge and learn how customers make decisions, and the frameworks we use to decode their behaviour, check out our course on Consumer Psychology.

#Consumerpsychology #Packaging #BehaviourChange #Marketing Image credit: Weider